CSBR:NASDAQ
Champions Oncology Inc
4,59 USD
arrow_downward
-1,89%(-0,088) 1D
17-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,70 USD
High
4,70 USD
Low
4,59 USD
Mkt. cap
63,91 млн
Avg. vol.
7,80 миң
Volume
4,85 миң
52-wk high
8,31 USD
52-wk low
4,52 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
Open
4,70 USD
High
4,70 USD
Low
4,59 USD
Mkt. cap
63,91 млн
Avg. vol.
7,80 миң
Volume
4,85 миң
52-wk high
8,31 USD
52-wk low
4,52 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
News stories
From web sources and news partners
TradingView
·
4 саат мурун
S&P 500, Dow, Nasdaq Futures Power Ahead On Nvidia Outlook Beat — NVDA, TSLA, ANT In Focus
BigGo Finance
·
6 саат мурун
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
ChartMill
·
6 саат мурун
S&P 500 After-Hours Gainers for Nov. 17, 2026
Traders Union
·
3 саат мурун
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersХаккенсак, Нью Джерси, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitechampionsoncology.com